22nd Century Group (NASDAQ: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced its appointment of John J. Miller to direct the growth and achieve the full potential of the company’s reduced nicotine tobacco business. Miller brings more than 35 years of experience in the tobacco and consumer packaged goods industries and a demonstrated ability to attain a track record of success and superior commercial results. “We are absolutely delighted to welcome John Miller to our team,” said Jim Mish, chief executive officer of 22nd Century Group. “His significant hands-on expertise and insight in strategic planning, assessing and implementing strategic partnership opportunities, and leading sales and marketing efforts will be instrumental in accelerating revenue, profit and market share growth for the company. We look forward to John’s contributions to the success of the company’s launch of VLN(R), our reduced nicotine cigarettes with 95% less nicotine than conventional cigarettes, which is the first and only modified risk tobacco product (‘MRTP’) approved by the FDA.”
To view the full press release, visit https://nnw.fm/GF00z
About 22nd Century Group Inc.
22nd Century Group is a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. With dozens of patents allowing it to control nicotine biosynthesis in the tobacco plant, the company has developed proprietary reduced nicotine content (“RNC”) tobacco plants and cigarettes, which have become the cornerstone of the FDA’s comprehensive plan to address the widespread death and disease caused by smoking. The company received the first and only FDA MRTP authorization of a combustible cigarette in December 2021. In tobacco, hemp/cannabis, and hop plants, 22nd Century uses modern plant-breeding technologies, including genetic engineering, gene-editing and molecular breeding to deliver solutions for the life science and consumer products industries by creating new, proprietary plants with optimized alkaloid and flavonoid profiles as well as improved yields and valuable agronomic traits. For more information about the company, visit www.XXIICentury.com.
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.networknewswire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork
